Abstract
Objective: The objective of the study was to assess the quality of life (QOL) of patients undergoing hemodialysis (HD). The QOL of HD patients was found to be considerably impaired when compared to that of healthy individuals of the general population. The careful assessment of QOL helps to guide and achieve medical management to optimize their health experience.Methods: Cross-sectional research design was adopted with 130 samples who met the inclusion criteria to conduct the study in the dialysis unit, India. The instrument used for the study was to collect the data are demographic variable and kidney disease QOL - short form version 1.3 scale.Results: The mean total score of QOL was 48.73±22.65, the highest score was for dialysis staff encouragement scale (84.04±14.89) followed by social support scale (80.38±20.38) and quality of social interaction (71.52±18.74). However, role limitation caused by physical health problems, role limitation caused by emotional health, and burden of kidney disease scales yielded the lowest scores (22.12±18.05, 26.92±24.15, and 38.03±12.81, respectively).Conclusion: The present study findings concluded that patients on HD were not having adequate QOL in all domains except patient satisfaction due to changes in the physiological, chemical changes occur in the kidney.
Highlights
Chronic diseases have become a major public health problem and the leading cause of morbidity and mortality [1]
The mean total score was 48.73±22.65; the highest score was for dialysis staff encouragement scale (84.04±14.89) followed by social support scale (80.38±20.38) and quality of social interaction (71.52±18.74)
It was found that majority of the patients were male and in the age group of 51 years and above were not having adequate quality of life (QOL) in the domains of physical health (PH), mental health, kidney disease problem and had better score in patient satisfaction (PS) which reveals that they had good encouragement and interaction with the dialysis staff of both medical and nursing
Summary
Chronic diseases have become a major public health problem and the leading cause of morbidity and mortality [1]. Endstage renal disease (ESRD) is one among the chronic diseases which possess great threat globally and increased burden in the healthcare system and leads to increased morbidity and mortality and decreased the quality of life (QOL) [3]. According to the World Health Organization, Global Burden of Disease project, diseases of the kidney and urinary tract contribute to global burden with approximately 8,50,000 deaths every year and 11,50,10,107 disability-adjusted life years. Chronic kidney disease (CKD) is the 12th leading cause of death and 17th cause of disability. CKD is associated with increased incidences of cardiovascular mortality and loss of disability-adjusted QOL years [5]. The approximate prevalence of CKD is 800 pmp and incidence of ESRD is 150–200 pmp [1]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Asian Journal of Pharmaceutical and Clinical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
